Cogentis Therapeutics

Cogentis Therapeutics

Signal active

Organization

Contact Information

Overview

Cogentis Therapeutics they develops therapeutics that prevent neurodegeneration and restore brain function to benefit the lives of those patients and their families.

About

Industries

Biotechnology, Service Industry, Health Care, Personal Health

Founded

2015

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Cogentis Therapeutics headquartered in United States, North America, operates in the Biotechnology, Service Industry, Health Care, Personal Health sector. With a team of 1-10 employees, Cogentis Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Non Equity Assistance - Cogentis Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Sean Evans

Sean Evans

Founder and Chief Business Development Officer

imagePlace Kent Werner

Kent Werner

Co-founder and CEO

Funding Rounds

Funding rounds

1

Investors

1

Lead Investors

0

Total Funding Amount

$0

Details

0

Cogentis Therapeutics has raised a total of $0 in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

Cogentis Therapeutics is funded by 3 investors.

Investor NameLead InvestorFunding RoundPartners
Scott Bailey-FUNDING ROUND - Scott Baileyundefined
Cogentis Therapeutics-FUNDING ROUND - Cogentis Therapeuticsundefined
MassChallenge-FUNDING ROUND - MassChallengeundefined

Recent Activity

There is no recent news or activity for this profile.